FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Review By Dilip Davda on April 5, 2021
Macrotech Developers Ltd. (erstwhile known as Lodha Developers Ltd.) has been trying to mop up huge money from the capital market since September 2009, but it could not see the light of the day on account of various reasons like disagreement on pricing of the IPO, bad market sentiments, dull atmosphere for the realty segment etc. The group also met with chaos on its some of the projects from the customers regarding quality of the work, delayed possessions, penalty for late payments etc. Now the IPO comes in the new name for which management clarified that while they are continuing their brand 'LODHA', they decided to change the name post-merger with one of its subsidiary and carrying its name for the merged entity.
Sudden change in lifestyle following pandemic, many have opted to shift to rural regions from urban and preferred affordable housing segment. This too had an impact on dull market sentiment in urban areas. Few other factors worth looking at in its September 2009, April 2018 DRHP and March 21 RHP are as under:
Particulars |
DRHP Sept 2009 |
DRHP April 2018 |
RHP March 2021 |
---|---|---|---|
FV |
Rs. 5 |
Rs. 10 |
Rs. 10 |
Issue Size |
Rs. 2790 cr. |
Rs. 3750 cr. |
Rs. 2500 cr. |
BRLMs |
Enam Secur (Now Axis Cap) J.P.Morgan Citigroup Global Nomura Fin Global Trust Cap Kotak Mahi Cap CLSA India Credit Suisse SBI Cap Total 9 BRLMs |
Kotak Mahi Cap CLSA India JM Financial Morgan Stanley BOB Cap Mkt Edelweiss Fin HDFC Bank ICICI Secur IIFL Holdings UBS Secur Yes Secur Total 11 BRLMs |
Axis Cap J.P.Morgan Kotak Mahi Cap ICICI Secur Edelweiss Fin IIFL Secur JM Financial Yes Secur SBI Capital Mkt BOB Capital Mkt Total 10 BRLMs |
Registrar |
Link Intime |
Link Intime |
Link Intime |
NB: The Company changed its name from Lodha Devlp to Macrotech Devlp in RHP
As per DRHP of April 2018, as on December 31, 2017, its total borrowings were Rs. 22327.21 cr. (page 520 of offer documents).
As per September 2009 and April 2018 DRHP it had appointed 9 and 11 BRLMs, and the issue size was for Rs. 2790 cr. And 3750 cr. Respectively. From this list of BRLM, we find names of CLSA India Pvt. Ltd., Morgan Stanley India Co. Ltd., HDFC Bank, UBS Securities missing and three new BRLMs included in March 2021 RHP are Axis Capital Ltd., J.P.Morgan India Pvt. Ltd., and SBI Capital Markets Ltd. March RHP indicates issue size of Rs. 2500 cr. With exchange of three BRLMs and withdrawal by 1 BRLM, the company has finally lowered fund raising target by Rs. 1250 cr.
Macrotech Developers Ltd. (MDL) is one of the largest real estate developers in India, by residential sales value for the financial years 2014 to 2020 (source: Anarock Report). Its core business is residential real estate developments with a focus on affordable and mid-income housing. Currently it has residential projects in the MMR and Pune. In 2019 it forayed into the development of logistics and industrial parks and entered into a joint venture with ESR Mumbai 3 Pte. Ltd.
The company also develops commercial real estate including as part of mixed use developments in and around its residential projects.
Its ongoing large projects portfolio includes Palava (Navi Mumbai - Dombivli Region), Amara, Lodha Sterling, Lodha Luxuria, Lodha Spendora, Crown and Upper at Thane, Bel Air (Jogeshwari), Lodha Belmondo (Pune), Casa Maxima (Mira Road). As of December 31, 2020 it has completed 91 projects of approx. 77.22 million sq. ft. (including 59.13 million affordable, 12.15 million mid-incomes and the rest in premium segment. It has 36 ongoing projects for approx. 830 acres developable area.
As on December 31, 2020 the aggregate outstanding borrowings of MDL stood at Rs. 18662.19 cr. Management clarified that with the on hand inventory realization, likely cash inflow for sold properties and under construction inventory realization, the company is likely to be debt free by 2023-24.
To part finance its plans for reducing outstanding borrowings (Rs. 1500.00 cr.), acquisition of land/land development rights (Rs. 375.00 cr.) and general corpus fund needs, MDL is coming out with a maiden IPO to mobilize Rs. 2500 cr. It has reserved shares worth Rs. 30 cr. (approx. 617280 shares), for eligible employees. From the residual portion, it has allocated 50% for QIBs, 15% for HNIs and 35% for retail investors. At the upper price band, MDL is likely to issue overall 51440340 equity shares of Rs. 10 each (including employees portion).
It has fixed a price band of Rs. 483 - Rs. 486 per equity share having a face value of Rs. 10 per share. The issue opens for subscription on April 07, 2021, and will close on April 09, 2021. Minimum application is to be made for 30 shares and in multiples thereon, thereafter. Post allotment, shares will be listed on BSE and NSE. The issue constitutes 11.50 % of the post issue paid-up capital of the company.
Joint Book Running Lead Managers (BRLMs) to this offer are Axis Capital Ltd., J.P. Morgan India Pvt. Ltd., Kotak Mahindra capital Co. Ltd., ICICI Securities Ltd., Edelweiss Financial Services Ltd., IIFL Securities Ltd., J M Financial Ltd., Yes Securities (India) Ltd., SBI Capital Markets Ltd., and BOB Capital Markets Ltd. while Link Intime India Pvt. Ltd. Is the registrar to the issue.
Having issued initial equity at par, the company raised further equity in the price range of Rs. 100 to Rs. 1000 (based on Face Value of Rs. 10 per share) between March 2005 and December 2016. It has also issued bonus shares in the ratio of 15 for 1 in September 2008, 99 for 1and 12 for 100 in September 2009 and 5 for 2 in December 2017.
The average cost of acquisition of shares by the promoters/selling stakeholders is Rs. NIL, Rs. 24.17 and Rs. 760.00 per share.
Post issue, MDL's current paid-up equity capital of Rs. 395.88 cr., will stand enhanced to Rs. 447.32 cr. Based on the upper price band, the company is looking for a market cap of Rs. 21739.67 cr.
On the financial performance front, on a consolidated basis, MDL has reported turnover/net profit (loss) of Rs. 13726.57 cr. / Rs. 1789.39 cr. (FY18), Rs. 11978.87 cr. / Rs. 1643.98 cr. (FY19) and Rs. 12560.99 cr. / Rs. 744.84 cr. (FY20). For the nine months' period ended on December 31, 2020, it has reported a net loss of Rs. - (264.30) cr., on a turnover of Rs. 3160.49 cr. While it posted inconsistency in top lines with declining bottom lines for the concluded three fiscals, it has posted negative earnings for the 9M FY21. Lower turnover and losses are attributed to impact of COVID-19 pandemic.
For the last three fiscals, the company has (on a consolidated basis) posted an average EPS of Rs. 30.52 per share and an average RoNW of 41.8 %.
If we include data from April 2018 DRHP for its working since FY2015, then, on a consolidated basis it has posted turnover/net profit of Rs. 6269.48 cr. / Rs. 798.01 cr. (FY15), Rs. 8290.95 cr. / Rs. 702.81 cr. (FY16) and Rs. 7957.33 cr. / Rs. 582.03 cr. (FY17). Thus for these three fiscals too it has shown inconstancy in top line while bottom lines have shown declining trends. If we add FY18 to FY20 data, then too it shows inconstancy in top line with declining trends in bottom lines. The most important is for 9M FY21 it has suffered losses which is attributed to pandemic scare.
The issue is priced at a P/BV of 5.01 based on its NAV of Rs. 97.03 per share as of December 31, 2020 (on a consolidated basis) and at a P/BV of 3.43 based on its post-IPO NAV of Rs. 141.76 per share (at the upper price band). Based on FY21 9M earnings, the issue is priced at a negative P/E. Based on its FY20 earnings, the issue is priced at a P/E of around 29.19 and thus it appears fully priced.
MDL has not paid any dividend for the last three fiscals as well as 9M-FY21, but will follow a prudent dividend policy based on its performance and future prospects.
As per offer documents, MDL has shown Brigade Enterprises, DLF Ltd., Godrej Properties, Oberoi Realty, Prestige Estates, Sobha Ltd., and Sunteck Realty as its listed peers. They are currently trading at a P/E of around 45.07, 00, 325.14, 59.27, 92.19, 42.12 and 100.86 (as of April 01, 2021). However, they are not truly comparable on an apple-to-apple basis.
The ten BRLMs associated with the offer have handled 38 public offers in the past three years, out of which 12 issues closed below the offer price on the listing date.
Based on its last three offer documents comparisons, latest financial data and rising scare following recurrence of pandemic, immediate future appears gloomy. The issue is priced at a negative P/E based on FY21-9M workings. Though IPO pricing appears lucrative, based on its current working and likely impact of continued corona scare in near term, its 'High Risk-Low Return' proposal. Considering all these, cash surplus - risk savvy investors may consider investment at their own risks in this IPO having negative P/E.
Review By Dilip Davda on April 5, 2021
DISCLAIMER: No financial information whatsoever published anywhere here should be construed as an offer to buy or sell securities, or as advice to do so in any way whatsoever. All matter published here is purely for educational and information purposes only and under no circumstances should be used for making investment decisions. Readers must consult a qualified financial advisor before making any actual investment decisions, based on the information published here. My reviews do not cover GMP market and operators game plans. Any reader taking decisions based on any information published here does so entirely at their own risk. Investors should bear in mind that any investment in stock markets is subject to unpredictable market-related risks. The above information is based on RHP and other documents available as of date coupled with market perception. The author has no plans to invest in this offer.
About Dilip Davda
Dilip Davda is veteran journalist associated with stock market since 1978. He is contributing to print and electronic media on stock markets/insurance/finance since 1985.
Dilip Davda is a leading reviewer of public issues and NCDs in the primary stock market in India. The knowledge he gained over 3 decades while working in the stock market and a strong relationship with popular lead managers makes his reviews unique. His detail fundamental and financial analysis of companies coming up with IPO helps investors in the primary stock market. Dilip Davda has a special interest in analyzing the SME companies and writing reviews about their public issues. His reviews are regularly published online and in news papers.
(Dilip Davda -SEBI registered Research Analyst-Mumbai,
Registration no. INH000003127 (Perpetual)
Email id: dilip_davda@rediffmail.com ).
The initial public offer (IPO) of Macrotech Developers Limited offers an early investment opportunity in Macrotech Developers Limited. A stock market investor can buy Lodha Developers IPO shares by applying in IPO before Macrotech Developers Limited shares get listed at the stock exchanges. An investor could invest in Lodha Developers IPO for short term listing gain or a long term.
Read the Lodha Developers IPO recommendations by the leading analyst and leading stock brokers.
Lodha Developers IPO offers an opportunity to buy IPO shares before they get listed at the stock exchanges. Read the Lodha Developers IPO Notes, Analysis and Recommendations by leading stock brokerage firms and experts in the above answer.
Our recommendation for Lodha Developers IPO is to subscribe for long term.
As per the analysis by our lead analyst Mr. Dilip Davda, we suggest you to subscribe for long term to the Lodha Developers IPO.
The Lodha Developers IPO allotment status will be available on or around April 16, 2021. The allotted shares will be credited in demat account by April 20, 2021. Visit Lodha Developers IPO allotment status to check.
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|